BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Annexon, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:36 pm Purchase |
2024-09-30 | 13G | Annexon, Inc. ANNX |
BIOTECHNOLOGY VALUE FUND L P | 9,027,778 8.400% |
2,027,778 (+28.97%) |
Filing |
| 2024-02-14 10:26 am Purchase |
2023-12-31 | 13G | Annexon, Inc. ANNX |
BIOTECHNOLOGY VALUE FUND L P | 7,000,000 8.900% |
3,219,306 (+85.15%) |
Filing |
| 2023-02-13 6:00 pm Purchase |
2022-12-31 | 13G | Annexon, Inc. ANNX |
BIOTECHNOLOGY VALUE FUND L P | 3,780,694 7.900% |
437,500 (+13.09%) |
Filing |
| 2022-05-26 5:09 pm Purchase |
2022-05-16 | 13G | Annexon, Inc. ANNX |
BIOTECHNOLOGY VALUE FUND L P | 3,343,194 8.700% |
3,343,194 (New Position) |
Filing |